Table 2. Comparison of the outpatient clinic-based ECV outcomes between the L-PeAF and post-AFCA patients.
| Overall (n=1,718) | L-PeAF (n=1,561) | Post-AFCA (n=157) | p value | ||
|---|---|---|---|---|---|
| ECV success | 1,523 (88.6) | 1,380 (88.4) | 143 (91.1) | 0.313 | |
| Successful ECV energy (J) | 144.0±69.5 | 146.2±69.1 | 122.2±70.0 | <0.001 | |
| Major complication | 8 (0.47) | 8 (0.51) | 0 (0.0) | 0.369 | |
| Stroke | 2 (0.12) | 2 (0.13) | 0 (0.0) | ||
| TIA | 1 (0.06) | 1 (0.07) | 0 (0.0) | ||
| SND requiring admission | 5 (0.29) | 5 (0.31) | 0 (0.0) | ||
| AF recurrence within 3 months | 845 (55.5) | 781 (56.6) | 64 (44.8) | 0.007 | |
| AF recurrence after 3 months | 323 (47.6) | 281 (46.9) | 42 (53.2) | 0.296 | |
| Follow-up months (25–75 percentile) | 32 (9–66) | 31 (9–65) | 41 (17–79) | 0.001 | |
Values are presented as number (%) or mean±standard deviation.
AF = atrial fibrillation; AFCA = atrial fibrillation catheter ablation; ECV = electrical cardioversion; L-PeAF = long-standing persistent atrial fibrillation; TIA = transient ischemic attack; SND = sinus node dysfunction.